Patrick Hwu: What an inspiring time at ASCO24 with our team at Moffitt Cancer Center
Patrick Hwu shared on LinkedIn:
“What an inspiring time at the American Society of Clinical Oncology (ASCO) annual meeting with our team at Moffitt Cancer Center and over 40,000 peers.
- More than 80 team members in attendance
- Science that will change practice
- Countless connections with colleagues
- So much hope for cancer patients everywhere
Coming together at ASCO is essential. Collaboration and the science shared these last few days will impact the many lives touched by cancer.
So proud of our team and all the bright minds who contribute to this collective mission!”
Source: Patrick Hwu/LinkedIn
Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy.
He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.